Community-acquired Pneumonia Among Smokers;Neumonía adquirida en la comunidad en fumadores

Archivos de Bronconeumologia

Volumn 50, Issue 6, 2014, Pages 250-254

  Almirall, Jordi ^a   Blanquer, José ^b   Bello, Salvador ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Community acquired pneumonia; Prevention; Risk factors; Smoking

Indexed keywords

PNEUMOCOCCUS VACCINE; PASSIVE SMOKING;

COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE PREDISPOSITION; HUMAN; LEGIONELLA PNEUMOPHILA; PASSIVE SMOKING; PERIODONTAL DISEASE; PROGNOSIS; RISK FACTOR; RISK REDUCTION; SEPTIC SHOCK; SHORT SURVEY; SMOKING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TOBACCO USE; UPPER RESPIRATORY TRACT INFECTION; AGE; COMMUNITY-ACQUIRED INFECTIONS; INCIDENCE; LEGIONNAIRES' DISEASE; MICROBIOLOGY; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; VACCINATION;

AGE FACTORS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DISEASE SUSCEPTIBILITY; HUMANS; INCIDENCE; LEGIONNAIRES' DISEASE; PNEUMOCOCCAL VACCINES; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION; VACCINATION;

EID: 85047696072     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2013.11.004     Document Type: Short Survey

References (66)

1. Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin Chest Med 2000, 21:11-35.
2. Almirall J., Bolibar I., Balanzó X., González C.A. Risk factors for community-acquired pneumonia in adults: A population-based case control study. Eur Respir J 1999, 13:349-355.
3. Almirall J., Gonzalez C.A., Balanzó X., Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999, 116:375-379.
4. Piatti G., Gazzola T., Allegra L. Bacterial adherence in smokers and non-smokers. Pharmacol Res 1997, 36:481-484.
5. Gil-Prieto R., García-García L., Álvaro-Meca A., Méndez C., García A., Gil de Miguel A. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007). Vaccine 2011, 29:412-416.
6. Almirall J., Rofes L., Serra-Prat M., Icart R., Palomera E., Arreola V., et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Resp J 2013, 41:923-928.
7. Almirall J., Bolibar I., Serra-Prat M., Roig J., Hospital I., Carandell E., et al. New evidence of risk factors for community-acquired pneumonia: A population-based study. Eur Resp J 2008, 31:1274-1284.
8. Vernooy J.H., Bracke K.R., Drummen N.E., Pauwels N.S., Zabeau L., van Suylen R.J., et al. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol 2010, 184:7169-7177.
9. Manzel L.J., Shi L., O'Shaughnessy P.T., Thorne P.S., Look D.C. Inhibition by cigarette smoke of nuclear factor-kB-dependent response to bacteria in the airway. Am J Respir Cell Mol Biol 2011, 44:155-165.
10. Feng Y., Kong Y., Barnes P., Huang F.F., Klucar P., Wang X., et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Imm 2011, 79:229-237.
11. Mortaz E., Kraneveld A.D., Smit J.J., Kool M., Lambrecht B.N., Kunkel S.L., et al. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS One 2009, 4:e4946.
12. Nizri E., Irony-Tur-Sinai M., Lory O., Orr-Urtreger A., Lavi E., Brenner T., et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 2009, 183:6681-6688.
13. Hodge S., Hodge G1, Ahern J. Smoking alters alveolar macrophage recognition and phagocytic ability. Am J Respir Cell Mol Biol 2007, 37:748-755.
14. Mehta H., Nazzal K., Sadikot R.T. Cigarette smoking and innate immunity. Inflamm Res 2008, 57:497-503.
15. Chung K.F., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006, 28:219-242.
16. Barnes P.J. Neutrophils find smoke attractive. Science 2010, 330:40-41.
17. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on inmunity, inflammation and autoimmunity. J Autoimmun 2010, 34:258-265.
18. Droemann D., Goldmann T., Tiedje T., Zabel P., Dalhoff K., Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68.
19. Vassallo R., Tamada K., Lau J.S., Kroening P.R., Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005, 175:2684-2691.
20. Qvarfordt I., Riise G.C., Andersson B.A., Larsson S. IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations. Thorax 2001, 56:445-449.
21. Modestou M.A., Manzel L.J., El-Mahdy S., Look D.C. Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke. Respir Res 2010, 11:64.
22. Bagaitkar J., Demuth R.D.R., Scott D.A. Tobacco use increases susceptibility to bacterial infection. Tob Ind Dis 2008, 4:12.
23. Huttunen R., Heikkinen T., Syrjänen J. Smoking and the outcome of infection. J Intern Med 2011, 269:258-269.
24. Oberg M., Jaakkola M.S., Woodward A., Peruga A., Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet 2011, 377:139-146.
25. Jiménez-Ruiz C.A., Miranda J.A., Hurt R.D., Pinedo A.R., Reina S.S., Valero S.C. Study of the impact of laws regulating tobacco consumption on the prevalence of passive smoking in Spain. Eur J Public Health 2008, 18:622-625.
26. Vinogradova Y., Hippisley-Cox J., Coupland C. Identification of new risk factors for pneumonia: Population-based case-control study. Br J Gen Pract 2009, 59:e882-e887.
27. Jones L.L., Hashim A., McKeever T., Cook D.G., Britton J., Leonardi-Bee J. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: Systematic review and meta-analysis. Respir Res 2011, 12:5.
28. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., Mc Geer A., Kolczak M.S., et al. Active bacterial core surveillance team. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000, 342:681-689.
29. Loeb M., Neupane B., Walter S.D., Hanning R., Carusone S.C., Lewis D., et al. Environmental risk factors for community-acquired pneumonia hospitalization in older adults. J Am Geriatr Soc 2009, 57:1036-1040.
30. Fernandez E., Krueger P., Loeb M. Predictors of health decline in older adults with pneumonia: Findings from the Community-Acquired Pneumonia Impact Study. BMC Geriatrics 2010, 10:1-7.
31. Strulovici-Barel Y., Omberg L., O'Mahony M., Gordon C., Hollmann C., Tilley A.E., et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med 2010, 182:1524-1532.
32. Hoffman L.H., Strutton D.R., Stang P.E., Hogue S.L. Impact of smoking on respiratory illness-related outpatient visits among 50-to 75-year-old in the United States. Clin Ther 2002, 24:317-324.
33. Pastor P., Medley F., Murphy T.V. Invasive pneumococcal disease in Dallas County, Texas: Results from population-based surveillance in 1995. Clin Infect Dis 1998, 26:590-595.
34. Raman A.S., Swinburne A.J., Fedullo A.Q.J. Pneumococcal adherente to the bucal epithelial cells of cigarette smokers. Chest 1983, 83:23-27.
35. Rueda A.M., Serpa J.A., Matloobi M., Mushtakq M., Musher D.M. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine 2012, 89:331-336.
36. Phipps J.C., Aronoff D.M., Curtis J.L., Goel D., O'Brien E., Mancuso P. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun 2010, 78:1214-1220.
37. Herr C., Beisswenger C., Hess C., Kandler K., Suttorp N., Welte T., et al. Suppression of pulmonary innate host defence in smokers. Thorax 2009, 64:144-149. for the CAPNETZ Study Group.
38. Kilsgard O., Andersson P., Malmsten M., Nordin S.L., Linge H.M., Eliasson M., et al. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37. Resulting in altered activities. Am J Respir Cell Mol Biol 2012, 46:240-248.
39. Gupta P.C., Pednekar M.S., Parkin D.M., Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 2005, 34:1395-1402.
40. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years'observations on male British doctors. BMJ 1994, 309:901-911.
41. Inoue Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al. Risk and protective factors related to mortality from pneumonia among middle aged and elderly community residents: The JACC Study. J Epidemiol 2007, 17:194-202.
42. Katanoda K., Marugame T., Saika K., Satoh H., Tajima K., Suzuki T., et al. Population attributable fraction of mortality associated with tobacco smoking in Japan: A pooled analysis of three large-scale cohort studies. J Epidemiol 2008, 18:251-264.
43. Fine M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S., Weissfeld L.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996, 275:134-141.
44. Jha P., Jacob B., Gajalakshmi V., Gupta P.C., Dhingra N., Kumar R., et al. A nationally representative case-control study of smoking and death in India. N Engl JMed 2008, 358:1137-1147.
45. Sitas F., Urban M., Bradshaw D., Kielkowski D., Bah S., Peto R. Tobacco attributable deaths in South Africa. Tob Control 2004, 13:396-399.
46. Garcia-Vidal C., Ardanuy C., Tubau F., Viasus D., Dorca J., Liñares J., et al. Pneumococcal pneumonia presenting with septic shock: Host- and pathogen related factors and outcomes. Thorax 2010, 65:77-81.
47. Naucler P., Darenberg J., Morfeldt E., Örtqvist A., Normark B.H. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax 2013, 68:571-579.
48. Roig J., Sabrià M., Pedro-Botet M.L. Legionell spp.: Community acquired and nosocomial infections. Curr Opin Infect Dis 2003, 16:145-151.
49. Sopena N., Sabrià M., Pedro-Botet M.L., Padilla E., Dominguez J., Morera J., et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998, 113:1195-1200.
50. Straus W.L., Plouffe J.F., File T.M., Lipman H.B., Hackman B.H., Salstrom S.J., et al. Risk factors for domestic acquisition of legionnaires disease. Arch Intern Med 1996, 156:1685-1692. Ohio Legionnaires Disease Group.
51. Arbes S.J., Agustsdottir H., Slade G.D. Environmental tobacco smoke and periodontal disease in the United Status. Am J Public Health 2001, 91:253-257.
52. Mojon P., Budtz-Jorgensen E., Michel J.P., Limeback H. Oral health and history of respiratory tract infection in frail institutionalised elders. Gerodontol 1997, 14:9-16.
53. Terpenning M.S., Taylor G.W., Lopatin D.E., Kerr C.K., Dominguez B.L., Loesche W.J. Aspiration pneumonia: Dental and oral risk factors in an older veteran population. J Am Geriatr Soc 2001, 49:557-563.
54. Tomar S.L., Asma S. Smoking-attributable periodontitis in the United States: Findings from NHANES III: Nacional Health and Nutrition Examination Survey. J Periodontol 2000, 71:743-751.
55. Blake G.H., Abell T.D., Stanley W.G. Cigarette smoking and upper respiratory infection among recruits in Basic combat training. Ann Intern Med 1988, 109:198-202.
56. Cohen S., Tyrrell D.A., Russell M.A., Jarvis M.J., Smith A.P. Smoking, alcohol consumption and susceptibility to the common cold. Am J Respir Cell Mol Biol 1996, 14:225-231.
57. Mandell L.A., Wunderink R.G., Anzuelo A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):527-572. Infectious Diseases Society of America: American Thoracic Society.
58. Centers for Disease Control and, Prevention. Recommended adult immunization, schedule, United, States, 2011 Proposed, Revisions. Advisory Committee on Immunization, Practices 2010.
59. Pearson W.S., Dube S.R., Ford E.S., Mokdah A.H. Influenza and pneumococcal vaccination rates among smokers: Data from the 2006 Behavioral Risk Factor Surveillance System. Prev Med 2009, 48:180-183.
60. Arcavi L., Benowitz N.L. Cigarette smoking and infection. Arch Intern Med 2004, 164:2206-2216.
61. Moberley S.A., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008, CD000422.
62. Torres A., Barberán J., Falguera M., Menéndez R., Molina J., Olaechea P., et al. Guía multidisciplinar para la valoración pronóstica, diagnóstica y tratamiento de la neumonía adquirida en la comunidad. Med Clin (Barc) 2013, 140:223-242.
63. Lazarus R., Clutterbuck E., Ly-Mee Y., Bowman J., Bateman E.A., Diggle L., et al. A randomized study comparing combined pneumococcal conjugate and polysacharide vaccination schedules in adults. Clin Infect Dis 2011, 52:736-742.
64. Feikin D.R., Klugman K.P. Historical changes in pneumococcal serogrup distribution: Implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002, 35:547-555.
65. Grau I., Ardanuy C., Calatayud L., Rolo D., Domenech A., Liñares J., et al. Invasive pneumococcal disease in healthy adults: Increase of empyema associated with the clonal-type Sweden1-ST306. PLoS One 2012, 7:e42595.
66. Picazo J.J., González-Romo F., García Rojas A., Pérez-Trallero E., Gil Gregorio P., de la Cámara R., et al. Consenso sobre la vacunación anti-neumocóccica en el adulto con patología de base. Rev Esp Quimioter 2013, 26:232-252.